rs10519177 — FBN1

FBN1 rs10519177 — The Recessive Aortic Variant: Two Copies Required for Risk

Fibrillin-1 is the primary structural protein of extracellular microfibrils¹¹ microfibrils
microscopic fibrous scaffolds embedded in connective tissue, giving the aortic wall its tensile strength and elasticity in the aortic wall. Mutations in FBN1 cause Marfan syndrome, but the gene also harbors common intronic variants that, without causing Marfan syndrome, can subtly degrade the aortic wall's resistance to dissection. rs10519177 is one such variant — but it behaves very differently from its better-known FBN1 neighbor rs2118181. Where rs2118181 elevates risk with a single risk allele, rs10519177 requires two copies of the G allele to produce a measurable biological effect.

The Mechanism

The variant sits at position c.4942+570 in an intron of FBN1, approximately 570 nucleotides downstream of exon 40. The FBN1 gene lies on the minus strand of chromosome 15; on the plus strand the alleles are A (reference) and G (risk). Like all intronic variants it does not change the fibrillin-1 amino acid sequence, but it can influence mRNA splicing efficiency, regulatory element binding, or expression levels in a dosage-sensitive way.

The key mechanistic clue comes from a 269-person study by Sepetiene et al. (Mol Med, 2015)²² Sepetiene et al. (Mol Med, 2015)
Sepetiene R, et al. Association between Fibrillin1 Polymorphisms and TGF-β1 Concentration in Human Plasma. Mol Med, 2015: elevating circulating TGF-β1 levels — the downstream consequence of impaired fibrillin-1 function — required two copies of the rs10519177 G allele. One copy alone produced no measurable effect. This recessive pattern contrasts sharply with rs2118181, where a single risk allele raised TGF-β1 by approximately 1 ng/mL. The implication is that rs10519177 has a weaker per-allele impact on fibrillin-1's TGF-β1 sequestration³³ TGF-β1 sequestration
fibrillin-1 normally binds and stores TGF-β1 in the extracellular matrix; when fibrillin-1 function is impaired, TGF-β1 is released into circulation, driving aortic wall inflammation and structural weakening capacity, and only the homozygous GG state is sufficient to push TGF-β1 meaningfully above baseline.

The Evidence

The strongest positive data come from a Lithuanian surgical cohort by Lesauskaite et al. (Eur J Cardiothorac Surg, 2015)⁴⁴ Lesauskaite et al. (Eur J Cardiothorac Surg, 2015) studying 312 patients who underwent aortic surgery against 472 reference subjects. The minor allele frequency of rs10519177 was significantly higher in aortic dissection patients compared to controls (p < 0.0001). Crucially, a recessive model best described the rs10519177 association with Stanford Type A aortic dissection — the most severe form requiring emergency open surgery — with an odds ratio of 4.31 (95% CI 2.06–9.01). This is a large effect size, but the confidence interval is wide, reflecting the rarity of GG homozygotes in the study population and the modest overall cohort size.

The picture is complicated by a null result: the Yale multicenter study by Iakoubova et al. (PLoS One, 2014)⁵⁵ Iakoubova et al. (PLoS One, 2014) — which included 140 TAD cases and 275 controls from the US, Hungary, and Greece — found that rs10519177 was not significantly associated with TAD, TAA, or combined TAAD. The same paper found rs2118181 significant (OR 1.87). One plausible explanation is statistical power: with a recessive model and G allele frequency of ~25% in Europeans, only about 6% of the population is GG, meaning a study of 275 controls would include fewer than 20 GG homozygotes — far too few to reliably detect a recessive effect. The Lithuanian cohort, larger and enriched for surgical cases, may have had sufficient GG representation.

Evidence overall is emerging: two studies with discordant results, no GWAS-level replication, and mechanistic data from a single moderate-sized cohort.

Practical Actions

The recessive pattern is clinically important: heterozygous AG carriers — the most common non-reference genotype at roughly 38% of people — appear biologically equivalent to AA homozygotes for this specific variant. The actionable concern applies to the rare GG group. For GG homozygotes, the recommendations parallel those for other FBN1 risk variants: establish baseline aortic dimensions, maintain tight blood pressure control, and recognize the warning signs of aortic dissection. Recognizing this variant's recessive pattern also means that genome-wide risk assessment for aortic disease should account for both rs10519177 (recessive) and rs2118181 (additive/dominant) separately — carrying one copy of each does not sum in a straightforward way.

Interactions

rs10519177 and rs2118181⁶⁶ rs2118181
the other well-studied intronic FBN1 variant, with a dominant/additive effect on TGF-β1 that acts with a single risk allele copy are likely in incomplete linkage disequilibrium — both are in the same FBN1 gene but show different inheritance patterns, suggesting they tag different functional elements. An individual who is GG at rs10519177 AND carries the rs2118181 C allele would have disruption from two independent fibrillin-1 mechanisms simultaneously. rs1036477 is a third FBN1 variant identified in the same Zhejiang Han cohort as correlated with increased mortality in male sTAAD patients. No compound analysis of all three variants together has been published.